Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics

This publication has 24 references indexed in Scilit:

• Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence
  The Journal of Steroid Biochemistry and Molecular Biology, 1995
• Genetic epidemiology of breast cancer
  Cancer, 1994
• Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs
  Journal of Medicinal Chemistry, 1993
• Multivariate analysis by the minimum spanning tree method of the structural determinants of diphenylethylenes and triphenylacrylonitriles implicated in estrogen receptor binding, protein kinase C activity, and MCF7 cell proliferation
  Journal of Medicinal Chemistry, 1992
• Potential Role of Tamoxifen in Prevention of Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Evaluation of the activity of some water‐soluble ferrocene and ferricenium compounds against carcinoma of the lung by the human tumor clonogenic assay
  Applied Organometallic Chemistry, 1990
• Effect of triphenylacrylonitrile derivatives on estradiol-receptor binding and on human breast cancer cell growth
  Journal of Medicinal Chemistry, 1989
• Non-platinum group metal antitumor agents. History, current status, and perspectives
  Chemical Reviews, 1987
• Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen
  The Journal of Steroid Biochemistry and Molecular Biology, 1982
• Some Methylquinolines Patterned as “Open Models” of Atebrin
  Journal of the American Chemical Society, 1946